Y-003(Shandong New Time Pharmaceutical)

N/A

Report date: 2024/05/20 20:00:11

Base Information

Drug NameY-003(Shandong New Time Pharmaceutical)

Drug Alias Name淫羊藿苷元Y-003(Shandong New Time Pharmaceutical)Y003(Shandong New Time Pharmaceutical)

ClassificationNatural product/Extract > Plants extract

Mechanisms of ActionMyeloid differentiation primary response protein MyD88 inhibitorsImmunomodulatorsInhibitor of nuclear factor kappa-B kinase subunit alpha inhibitors +[4]

TargetsMyeloid differentiation primary response protein MyD88Inhibitor of nuclear factor kappa-B kinase subunit alphaEstrogen receptor beta

Therapy Area/IndicationsPurpura, Thrombocytopenic, Idiopathic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesShandong New Time Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShandong New Time Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsPurpura, Thrombocytopenic, Idiopathic

Inactive IndicationsN/A

Other Information

ATC CodeN/A